Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.

A natural killer–dendritic cell axis defines checkpoint therapy–responsive tumor microenvironments

Open access

Abstract

Intratumoral stimulatory dendritic cells (SDCs) play an important role in stimulating cytotoxic T cells and driving immune responses against cancer. Understanding the mechanisms that regulate their abundance in the tumor microenvironment (TME) could unveil new therapeutic opportunities. We find that in human melanoma, SDC abundance is associated with intratumoral expression of the gene encoding the cytokine FLT3LG. FLT3LG is predominantly produced by lymphocytes, notably natural killer (NK) cells in mouse and human tumors. NK cells stably form conjugates with SDCs in the mouse TME, and genetic and cellular ablation of NK cells in mice demonstrates their importance in positively regulating SDC abundance in tumor through production of FLT3L. Although anti-PD-1 'checkpoint' immunotherapy for cancer largely targets T cells, we find that NK cell frequency correlates with protective SDCs in human cancers, with patient responsiveness to anti-PD-1 immunotherapy, and with increased overall survival. Our studies reveal that innate immune SDCs and NK cells cluster together as an excellent prognostic tool for T cell-directed immunotherapy and that these innate cells are necessary for enhanced T cell tumor responses, suggesting this axis as a target for new therapies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41591-018-0085-8

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 46 references

Cited by

See all 1,021

Metadata

Authors
Barry, K. C., Hsu, J., Broz, M. L., Cueto, F. J., Binnewies, M., Combes, A. J., Nelson, A. E., Loo, K., Kumar, R., Rosenblum, M. D., Alvarado, M. D., Wolf, D. M., Bogunovic, D., Bhardwaj, N., Daud, A. I., Ha, P. K., Ryan, W. R., Pollack, J. L., Samad, B., Asthana, S., Chan, V., & Krummel, M. F.
Affiliations
  • University of California, San Francisco (US)
  • Icahn School of Medicine at Mount Sinai (US)
  • Tisch Cancer Institute (US)
Corresponding author
Krummel, Matthew F.
Venue
Nature Medicine
Published
2018-06-25
Volume
24
Issue
8
Pages
1178-1191
ISSN
  • 1078-8956 (ISSN-L)
  • 1546-170X
OpenAlex
W2808909747
Cited by
1,021
References
46
Citations by year
2026: 77 · 2025: 118 · 2024: 136 · 2023: 146 · 2022: 140 · 2021: 132 · 2020: 162 · 2019: 95 · 2018: 13
FWCI
38.25
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
  • National Institutes of Health (1dp2ar068130-01)
  • National Cancer Institute (P30CA082103, R01CA197363)
  • National Institute of Allergy and Infectious Diseases (T32AI007334, R01AI114787)
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (DP2-AR068130)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (T32HD007470)
Topics
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
Keywords
natural killer cells, dendritic cells, tumor microenvironment, Flt3L, melanoma, anti-PD-1 therapy, immune checkpoint therapy, prognostic factors, T cell response, innate immunity, overall survival
MeSH terms
Antigens, Surface, Cell Communication, Cell Survival, Dendritic Cells, Humans, Immunotherapy, Killer Cells, Natural, Lymphocytes, Melanoma, Membrane Proteins, Survival Analysis, Thrombomodulin, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A natural killer–dendritic cell axis defines checkpoint therapy–responsive tumor microenvironments. https://app.cochat.ai/papers/10.1038/s41591-018-0085-8
The paper
Barry, K. C., Hsu, J., Broz, M. L., Cueto, F. J., Binnewies, M., Combes, A. J., Nelson, A. E., Loo, K., Kumar, R., Rosenblum, M. D., Alvarado, M. D., Wolf, D. M., Bogunovic, D., Bhardwaj, N., Daud, A. I., Ha, P. K., Ryan, W. R., Pollack, J. L., Samad, B., . . . Krummel, M. F. (2018). A natural killer–dendritic cell axis defines checkpoint therapy–responsive tumor microenvironments. Nature Medicine. https://doi.org/10.1038/s41591-018-0085-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.